CDKN2A and breast carcinoma: Most BRCA1-deficient breast cancers carry a dysfunctional INK4-CDK4/6-RB pathway 13, 40, 41, All widely used BRCA1 mutant breast cancer cell lines have deletions in either RB or p16 42, 43.